Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia
Our personalized approach, which thoroughly evaluates factors like metabolism, hormonal balance, medical history, and lifestyle, helps optimize your results
10.1021/acs.jproteome.5b00144 34
10.3389/fimmu.2019.01050 Summary Keywords T2DM, incretin effect, DPP-4 enzyme, DPP-4 inhibitors, (GLP)-1, insulin Citation Saini K, Sharma S and Khan Y (2023) DPP-4 inhibitors for treating T2DM - hype or hope
Reddy s Laboratories Ltd., Lupin Limited, Intas Pharmaceuticals Ltd., Alvotech, Bio-Thera Solutions Ltd., Organon & Co., Fresenius Kabi AG, Coherus BioSciences Inc., Dong-A ST Co., Ltd., Gan & Lee Pharmaceuticals, Hikma Pharmaceuticals PLC, Shanghai Henlius Biotech Inc., and Zhejiang Huahai Pharmaceutical Co., Ltd
We focus on Type I and Type III collagen because these are the primary types found in the skin and connective tissues